Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap6.74B
Enterprise Value6.79B
P/E Ratio39.59
PEG Ratio0.81
Price/Sales Ratio3.39
Price/Book Ratio2.72
Enterprise/Revenue3.59
Enterprise/EBITDA21.91

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.09
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.07

Income Statement

Revenue1.42B
Revenue/Share6.77
Gross Profit526.55M
EBITDA271.87M
Net Income125.44M
Diluted EPS0.62

Balance Sheet

Total Cash834.84M
Total Cash/Share4.26
Total Debt812.45M
Total Debt/Equity0.49
Current Ratio1.99
Book Value Per Share9.7

Price History

52-Week Change-38.61
52-Week High48.9
52-Week Low22.22
Moving Average 50 Days24.95
Moving Average 200 Days30.69

Statistics

Average Volume11.94M
Shares Outstanding196.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield1.09
Payout Ratio0.69
Last Split Factor29:20
Last Split DateMay 19, 2023
AD